Submit Here

A Retrospective Analysis of Cervical Cytology Report of Women Screened by a Non-governmental Organization in Rivers State, Nigeria.

November 11, 2020
Advertisements

Okoh et al

Greener Journal of Medical Sciences

Vol. 10(2), pp. 46-49, 2020

ISSN: 2276-7797

Copyright ©2020, the copyright of this article is retained by the author(s)

https://gjournals.org/GJMS

  

 

 

 

 

 

A Retrospective Analysis of Cervical Cytology Report of Women Screened by a Non-governmental Organization in Rivers State, Nigeria.

 

 

Okoh DA1, Iwo–Amah RS2, Briggs NCT3, Musa IS4, Oguzor UC5

 

 

Preventive Health Initiative.1

Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital.2

Department of Community Medicine, Rivers State University.3

Department of Anatomical Pathology, Federal Medical Centre, Yenagoa.4

Department of Family Medicine, Rivers State University Teaching Hospital.5

 

 

ARTICLE INFO ABSTRACT
 

Article No.: 102920136

Type: Research

 

  

Introduction: Cervical cancer is a preventable genital tract malignancy, with majority of the patients presenting in the advanced stages in the developing countries of the world due to poor screening. However in the developed countries of the world through organized screening modalities of cervical cancer over 80% of mortalities are prevented annually. Cervical cancer is the fourth most common cancer among women world -wide, but in developing countries like Nigeria, it is second only to breast cancer. There were estimated 570,000 new cases and 311,000 deaths from cervical cancer in 2018.

Aim/Objective: 1. To determine the secondary prevention of cervical cancer and timely treatment of precancerous lesions. 2. To highlight the poor up take of these screening methods in new and middle income countries (LMICS), especially Nigeria.

Method: This was a retrospective study conducted over eleven year period by a nongovernmental organization during a medical outreach. Enlightenment campaign on cervical cancer was carried out involving two hundred after which consent given by them for cytology screening using the Pap smear described by Dr. George Papanicolaou. The information was analyzed by simple statistical method.

Results: Two hundred women were analyzed. Their ages were between 25 and 73 years  (majority, over 90% were of the reproductive ages 40 to 49 years). One hundred and sixty (80%) of the subjects had never heard of cervical cancer; 196 (98%) were undergoing Pap smear screening for the first time. One hundred and ninety (85%) were negative for precancerous lesions, 10 (5%) of the women had precancerous lesions, 8(4%) had Low Grade Squamous Intra-epithelial Lesion (LGSIL), 1( 0.5%) had High Grade Squamous Intra-epithelial Lesions and 1 (0.5%) had Atypical Squamous Cells of Undetermined Significance (ASCUS).

Conclusion: The study revealed that the awareness of cervical cancer was poor represented by 80% of the respondents.  In addition, the study showed that majority of the respondents were undergoing cervical cancer screening for the first time, represented by 95% of the respondents.  There is need for awareness and enlightenment for cervical cancer prevention by Government and Nongovernmental organizations to the general public to prevent mortalities from the disease burden
 

Accepted:  29/10/2020

Published: 11/11/2020
 

*Corresponding Author

Dr. Okoh DA

E-mail: daokoh@ gmail.com
 

Keywords:

Cervical cancer; cytology; screening; Rivers State; Nigeria
   
Return to Content       View [Full Article – PDF]

[Full Article – HTML]              [Full Article – EPUB]

 

 

REFERENCES:

 

  1. Okeke TC, Onuh N, Ikeako LC, Ezenyeaku CCT. The Frequency and Pattern of Female Genital Malignancies at The University of Nigeria Teaching Hospital, Enugu, Nigeria. Ann Med Health Sci. Res 2013; 3: 343-8.
  2. Seleye-Fubara O, Uzoigwe SA. Pattern of primary female genital cancer in Port Harcourt, Nigeria. A 12-year review. Sahel Med J 2003; 6: 34-9.
  3. Anorlu RI. Cervical cancer: The sub-saharan African perspective. Reproductive Health Matters 2008; 16:41-9.
  4.    Siegel RL, Miller KD, Jemal A. Cancer J Clin 2020; 70: 7-30.
  5. Daniel CN, Emmanuel IN, Arede L, Magaj A. Screening for cervical cancer experience from a university hospital in north western Nigeria (2007-2009). Journal of Basic and Clinical Reproductive Sciences 2013; 2(1): 18.
  6. Tesfaye ZT, Bhagawathula A, Gabreyohurines EA. Knowledge and Awareness of Cervical Cancer and Human Papillomavirus among female students in Ethiopia University: A cross-sectional study. International Journal of Preventable Medicine 2019; 10(1): 198.
  7. Udofia E, Awaoro CD, Ekanem U. Awareness, use and main source of information on preventive health examinations: a survey of childbearing women in Uyo, Nigeria. African Journal of Reproductive Health 2012; 16(4): 149-61.
  8. Ofuebe J, Omaka LN, Asogwa BO, Agu MA. Knowledge and use of cervical cancer screening for cancer prevention by Reproductive age women. Global Journal of health sciences 2019; 11(7); 47-52.
  9. Islami F, Fedena SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity histological subtype and stage at diagnosis in the United States. Prev Med 2019; 123: 310-323.
  10. Toye et al. Knowledge, perception and practice of cervical cancer prevention among female public secondary school teachers in Mushin local government area of Lagos state, Nigeria. Pan African Medical Journal 2017; 28: 221.
  11. Ahmed SA, Sabitu K, Idris SH, Ahmed R. Knowledge, attitude and practice of cervical cancer screening among market women in Zaria, Nigeria. Nigeria Med J 2013; 54: 316-9.
  12. Okunowo AA, Smith-Okonu ST. Cervical cancer screening among urban women in Lagos, Nigeria: Focus on barriers and motivations for screening. Niger J Gen Pract 2020; 18(1): 10-16.
  13. Nwankwo KC, Aniebue U, Aguwa EN, Anarado AN, Aguruwan E. Knowledge, attitudes and practice of cervical cancer screening among urban and rural Nigerian women a call for education and mass screening. Eur J Cancer Care 2011; 20(3): 362-367.
  14. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao TH et al. A new HPV-DNA test for cervical cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008: 9(10): 929-936.
  15. Brown DR, Wilson RM, Boothe MA, Harris CE. Cervical cancer screening among ethnically diverse black women knowledge, attitudes, beliefs and practices. J Nat Med Assoc 2011; 103(8): 718-728.
  16. Kiristic A, Lang K, Baili P, Antila A, Veems P. Women’s knowledge about cervical cancer risk factors, screening programme in Estonia. BMC Women’s Health 2011; 11:43.
  17. Thomas J, Ojemakinde O, Izebraye I. Current concepts in cervical carcinogenesis and new prospective in prevention. Arch Ibadan Med. 2002; 3(1): 56-9.
  18. Ferlay J, Shin HR, Bray F, Forman D, Matthas C, Parker DM. Estimates of worldwide burden of cancer in 2008. GLOBACAN Int J Cancer 2010;127(12): 2893-917.
  19. Munoz N, Bosch FX, de Sanjose S, Herero R, Castellsague X, Shah VK et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 2008; 348(6): 518-27.
  20. Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, Opiyo A et al. Knowedge and practices about cervical cancer and Pap smear testing among patients at Kenyetta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer 2003; 13(6): 827-833.

 

Cite this Article: Okoh, DA; Iwo–Amah, RS; Briggs, NCT; Musa, IS; Oguzor, UC (2020). A Retrospective Analysis of Cervical Cytology Report of Women Screened by a Non-governmental Organization in Rivers State, Nigeria. Greener Journal of Medical Sciences, 10(2): 46-49.

Journal Name : citation_journal : Greener Journal of  Medical Sciences

Leave a Reply

Your email address will not be published. Required fields are marked *